(ELF) ELF Beauty - Ratings and Ratios
Cosmetics, Skincare, Eye, Lip, Face
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 67.6% |
| Value at Risk 5%th | 96.6% |
| Relative Tail Risk | -13.10% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.22 |
| Alpha | -60.38 |
| CAGR/Max DD | 0.24 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.583 |
| Beta | 1.585 |
| Beta Downside | 1.442 |
| Drawdowns 3y | |
|---|---|
| Max DD | 77.09% |
| Mean DD | 29.08% |
| Median DD | 26.32% |
Description: ELF ELF Beauty January 08, 2026
e.l.f. Beauty, Inc. (NYSE:ELF) is a U.S.-based personal-care company that markets cosmetics and skin-care products under the e.l.f. Cosmetics, e.l.f. Skin, Well People, Naturium, and Keys Soulcare brands. Its portfolio spans eye, lip, face, “paw” (nail), and skin-care categories, and the firm distributes through both traditional retail partners and a growing direct-to-consumer (DTC) e-commerce channel.
Since its 2004 founding and the 2016 rebranding from J.A. Cosmetics Holdings, ELF has leveraged a value-priced, “clean-beauty” positioning to capture price-sensitive consumers. In FY 2023 the company reported net revenue of roughly $1.5 billion, representing a 13 % year-over-year increase, with DTC sales accounting for about 40 % of total revenue-an indicator of accelerating online penetration. Gross margins hovered near 78 %, reflecting a lean product mix and efficient supply-chain management.
Key macro drivers for ELF include the continued shift toward affordable, cruelty-free cosmetics, strong e-commerce growth in the personal-care sector, and resilient consumer spending on “self-care” even in a higher-interest-rate environment. For a deeper quantitative dive, the ValueRay platform provides a granular breakdown of ELF’s valuation multiples and forward cash-flow projections.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (81.8m TTM) > 0 and > 6% of Revenue (6% = 83.1m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 4.29pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 32.14% (prev 19.97%; Δ 12.17pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 172.0m > Net Income 81.8m (YES >=105%, WARN >=100%) |
| Net Debt (723.4m) to EBITDA (190.3m) ratio: 3.80 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.70 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (59.6m) change vs 12m ago 1.90% (target <= -2.0% for YES) |
| Gross Margin 70.27% (prev 71.00%; Δ -0.72pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 77.94% (prev 98.43%; Δ -20.50pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 7.62 (EBITDA TTM 190.3m / Interest Expense TTM 18.2m) >= 6 (WARN >= 3) |
Altman Z'' 1.45
| (A) 0.19 = (Total Current Assets 707.2m - Total Current Liabilities 261.9m) / Total Assets 2.32b |
| (B) -0.06 = Retained Earnings (Balance) -145.9m / Total Assets 2.32b |
| (C) 0.08 = EBIT TTM 138.4m / Avg Total Assets 1.78b |
| (D) -0.12 = Book Value of Equity -144.4m / Total Liabilities 1.18b |
| Total Rating: 1.45 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 58.71
| 1. Piotroski 4.0pt |
| 2. FCF Yield 2.65% |
| 3. FCF Margin 10.25% |
| 4. Debt/Equity 0.81 |
| 5. Debt/Ebitda 3.80 |
| 6. ROIC - WACC (= -2.47)% |
| 7. RoE 9.43% |
| 8. Rev. Trend 95.17% |
| 9. EPS Trend 25.34% |
What is the price of ELF shares?
Over the past week, the price has changed by +7.97%, over one month by +6.24%, over three months by -41.61% and over the past year by -35.73%.
Is ELF a buy, sell or hold?
- Strong Buy: 9
- Buy: 3
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ELF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 115.4 | 40.6% |
| Analysts Target Price | 115.4 | 40.6% |
| ValueRay Target Price | 80.8 | -1.5% |
ELF Fundamental Data Overview January 04, 2026
P/E Trailing = 55.5786
P/E Forward = 21.978
P/S = 3.3489
P/B = 3.9813
P/EG = 2.03
Beta = 1.738
Revenue TTM = 1.39b USD
EBIT TTM = 138.4m USD
EBITDA TTM = 190.3m USD
Long Term Debt = 831.6m USD (from longTermDebt, last quarter)
Short Term Debt = 30.6m USD (from shortTermDebt, last quarter)
Debt = 917.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 723.4m USD (from netDebt column, last quarter)
Enterprise Value = 5.36b USD (4.64b + Debt 917.8m - CCE 194.4m)
Interest Coverage Ratio = 7.62 (Ebit TTM 138.4m / Interest Expense TTM 18.2m)
FCF Yield = 2.65% (FCF TTM 142.0m / Enterprise Value 5.36b)
FCF Margin = 10.25% (FCF TTM 142.0m / Revenue TTM 1.39b)
Net Margin = 5.90% (Net Income TTM 81.8m / Revenue TTM 1.39b)
Gross Margin = 70.27% ((Revenue TTM 1.39b - Cost of Revenue TTM 411.9m) / Revenue TTM)
Gross Margin QoQ = 69.45% (prev 69.13%)
Tobins Q-Ratio = 2.31 (Enterprise Value 5.36b / Total Assets 2.32b)
Interest Expense / Debt = 1.00% (Interest Expense 9.15m / Debt 917.8m)
Taxrate = 175.1% (out of range, set to none) (-6.99m / -3.99m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 2.70 (Total Current Assets 707.2m / Total Current Liabilities 261.9m)
Debt / Equity = 0.81 (Debt 917.8m / totalStockholderEquity, last quarter 1.14b)
Debt / EBITDA = 3.80 (Net Debt 723.4m / EBITDA 190.3m)
Debt / FCF = 5.10 (Net Debt 723.4m / FCF TTM 142.0m)
Total Stockholder Equity = 868.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.53% (Net Income 81.8m / Total Assets 2.32b)
RoE = 9.43% (Net Income TTM 81.8m / Total Stockholder Equity 868.0m)
RoCE = 8.15% (EBIT 138.4m / Capital Employed (Equity 868.0m + L.T.Debt 831.6m))
RoIC = 7.43% (EBIT 138.4m / (Assets 2.32b - Curr.Liab 261.9m - Cash 194.4m))
WACC = 9.90% (E(4.64b)/V(5.56b) * Re(11.86%) + (debt cost/tax rate unavailable))
Discount Rate = 11.86% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 2.69%
[DCF Debug] Terminal Value 70.04% ; FCFE base≈94.3m ; Y1≈116.3m ; Y5≈198.4m
Fair Price DCF = 31.54 (DCF Value 1.88b / Shares Outstanding 59.6m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 25.34 | EPS CAGR: -24.23% | SUE: -4.0 | # QB: 0
Revenue Correlation: 95.17 | Revenue CAGR: 39.72% | SUE: -2.01 | # QB: 0
EPS current Year (2026-03-31): EPS=2.85 | Chg30d=-0.000 | Revisions Net=-1 | Growth EPS=-16.0% | Growth Revenue=+19.3%
EPS next Year (2027-03-31): EPS=3.53 | Chg30d=+0.006 | Revisions Net=+0 | Growth EPS=+23.9% | Growth Revenue=+16.8%
Additional Sources for ELF Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle